Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gadina

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Vitamins and Hormones|October 10, 2006
The newest interleukins: recent additions to the ever-growing cytokine familyQian Chen, Helen P Carroll, Massimo Gadina
Science Immunology|May 10, 2020
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina
Frontiers in Immunology|April 29, 2017
HiJAKing Innate Lymphoid Cells?Giuseppe Sciumè, Mimi T Le, Massimo Gadina
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2011
Cytokine signaling: birth of a pathwayJohn J O'Shea, Massimo Gadina, Yuka Kanno
The Journal of Pharmacy and Pharmacology|March 10, 2004
Inhibiting cytokines of the interleukin-12 family: recent advances and novel challengesKoen Vandenbroeck, Iraide Alloza, Massimo Gadina, et al.
Current Opinion in Infectious Diseases|June 25, 2003
New interleukins: are there any more?Massimo Gadina, Paul R Ferguson, James A Johnston
Rheumatology (Oxford, England)|May 5, 2021
JAK1: Number one in the family; number one in inflammation?Francesca Romana Spinelli, Robert A Colbert, Massimo Gadina
Cell|May 2, 2002
Cytokine signaling in 2002: new surprises in the Jak/Stat pathwayJohn J O'Shea, Massimo Gadina, Robert D Schreiber
Journal of Autoimmunity|July 6, 2017
Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseasesMassimo Gadina, Nathalia Gazaniga, Laura Vian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNKAndrea la Sala, Massimo Gadina, Brian L Kelsall
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Vitamins and Hormones|October 10, 2006
The newest interleukins: recent additions to the ever-growing cytokine familyQian Chen, Helen P Carroll, Massimo Gadina
Science Immunology|May 10, 2020
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina
Frontiers in Immunology|April 29, 2017
HiJAKing Innate Lymphoid Cells?Giuseppe Sciumè, Mimi T Le, Massimo Gadina
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2011
Cytokine signaling: birth of a pathwayJohn J O'Shea, Massimo Gadina, Yuka Kanno
The Journal of Pharmacy and Pharmacology|March 10, 2004
Inhibiting cytokines of the interleukin-12 family: recent advances and novel challengesKoen Vandenbroeck, Iraide Alloza, Massimo Gadina, et al.
Current Opinion in Infectious Diseases|June 25, 2003
New interleukins: are there any more?Massimo Gadina, Paul R Ferguson, James A Johnston
Rheumatology (Oxford, England)|May 5, 2021
JAK1: Number one in the family; number one in inflammation?Francesca Romana Spinelli, Robert A Colbert, Massimo Gadina
Cell|May 2, 2002
Cytokine signaling in 2002: new surprises in the Jak/Stat pathwayJohn J O'Shea, Massimo Gadina, Robert D Schreiber
Journal of Autoimmunity|July 6, 2017
Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseasesMassimo Gadina, Nathalia Gazaniga, Laura Vian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNKAndrea la Sala, Massimo Gadina, Brian L Kelsall
Pageof 13